Aceclidine

DRUG2 trials

Sponsors

LENZ Therapeutics, Inc

Conditions

AceclidineBrimonidine TartrateEye DiseasesOphthalmic SolutionsPresbyopiaRefractive Errors

Phase 1

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

CompletedNCT05936489

LENZ Therapeutics, IncAceclidine, Brimonidine Tartrate, Eye Diseases +3

Start: 2023-07-06End: 2023-10-03Updated: 2023-10-16

Phase 2

A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

CompletedNCT03201562

LENZ Therapeutics, IncPresbyopia

Start: 2017-04-30End: 2018-05-20Updated: 2022-09-22